Davis Polk & Wardwell, Mayer Brown, and Mishcon de Reya advised Gilead, while Goodwin Procter and Wilson Sonsini Goodrich & Rosati advised MiroBio on the deal....
Gilead Sciences’ $405 Million Acquisition of MiroBio
MiroBio’s $97 Million Series B Financing
Wilson Sonsini Goodrich & Rosati and Goodwin advised MiroBio on the deal. MiroBio, a leader in the development of checkpoint agonists to treat autoimmune diseases, announced...